MGI
BMRN icon

Miller Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Miller Global Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Hold
8,696
– – 0.41% 88
2026
Q1 		$491K Hold
8,696
– – 0.45% 73
2025
Q4 		$517K Buy
+8,696
New +$473K 0.47% 69

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Miller Global Investments's BMRN Position: Q2 2026 in Review

Miller Global Investments held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 8,696 shares worth $498K. The position accounts for 0.41% of the portfolio, ranked #88.

Miller Global Investments first reported a position in BMRN in Q4 2025 and has held it in 3 quarters since. The position peaked at $517K in Q4 2025. 207 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Miller Global Investments held 8,696 shares of BioMarin Pharmaceuticals worth $498K as of Q2 2026.
  • Miller Global Investments left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.41% of Miller Global Investments's portfolio in Q2 2026, its #88 holding.
  • Miller Global Investments first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's BioMarin Pharmaceuticals position peaked at $517K in Q4 2025.
  • 207 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.